These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28770545)

  • 1. How to reduce cisatracurium consumption in ARDS patients: the TOF-ARDS study.
    Hraiech S; Forel JM; Guervilly C; Rambaud R; Lehingue S; Adda M; Sylla P; Valera S; Carvelli J; Gainnier M; Papazian L; Bourenne J
    Ann Intensive Care; 2017 Dec; 7(1):79. PubMed ID: 28770545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Best evidence in critical care medicine: The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome.
    Needham CJ; Brindley PG
    Can J Anaesth; 2012 Jan; 59(1):105-8. PubMed ID: 22042702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Fixed Dosing vs Train of Four Titration of Cisatracurium in COVID-19 ARDS Patients.
    Banerjee O; Elefritz JL; Doepker BA; Atyia SA; Brummel NE; Smith RM; Handley D; Cape KM
    J Pharm Pract; 2024 Oct; 37(5):1082-1090. PubMed ID: 38087423
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of Cisatracurium Versus Atracurium in Early ARDS.
    Moore L; Kramer CJ; Delcoix-Lopes S; Modrykamien AM
    Respir Care; 2017 Jul; 62(7):947-952. PubMed ID: 28351905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Cisatracurium Compared to Vecuronium for Neuromuscular Blockade in Acute Respiratory Distress Syndrome.
    Vallabh P; Ha M; Ahern K
    J Intensive Care Med; 2023 Feb; 38(2):188-195. PubMed ID: 35821572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of fixed dose versus train-of-four titration of cisatracurium in acute respiratory distress syndrome.
    Thompson Bastin ML; Smith RR; Bissell BD; Wolf HN; Wiegand AM; Cavagnini ME; Ahmad Y; Flannery AH
    J Crit Care; 2021 Oct; 65():86-90. PubMed ID: 34118504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical assessment and train-of-four measurements in critically ill patients treated with recommended doses of cisatracurium or atracurium for neuromuscular blockade: a prospective descriptive study.
    Bouju P; Tadié JM; Barbarot N; Letheulle J; Uhel F; Fillatre P; Grillet G; Goepp A; Le Tulzo Y; Gacouin A
    Ann Intensive Care; 2017 Dec; 7(1):10. PubMed ID: 28102521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromuscular blockade in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Ho ATN; Patolia S; Guervilly C
    J Intensive Care; 2020; 8():12. PubMed ID: 32015880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Cisatracurium Continuous Infusion Dose in Acute Respiratory Distress Syndrome.
    Merkel A; Massey K; Bellamy C; Miano T; Fuchs B; Candeloro C
    J Pharm Pract; 2021 Aug; 34(4):600-605. PubMed ID: 31736402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compared efficacy and tolerance of the neuromuscular blockade induced by brand-name (Nimbex®) and generic (Cisatrex®) of cisatracurium in mechanically ventilated critically ill patients: a crossover double-blind randomized study.
    Fraj N; Meddeb K; Azouzi A; Romdhani S; Saad HB; Boussarsar M
    Pan Afr Med J; 2020; 37():346. PubMed ID: 33738034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome.
    Guervilly C; Bisbal M; Forel JM; Mechati M; Lehingue S; Bourenne J; Perrin G; Rambaud R; Adda M; Hraiech S; Marchi E; Roch A; Gainnier M; Papazian L
    Intensive Care Med; 2017 Mar; 43(3):408-418. PubMed ID: 28013329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome.
    Mefford B; Donaldson JC; Bissell BD
    Ann Pharmacother; 2020 Sep; 54(9):899-906. PubMed ID: 32111121
    [No Abstract]   [Full Text] [Related]  

  • 13. A prospective randomized comparison of train-of-four monitoring and clinical assessment during continuous ICU cisatracurium paralysis.
    Baumann MH; McAlpin BW; Brown K; Patel P; Ahmad I; Stewart R; Petrini M
    Chest; 2004 Oct; 126(4):1267-73. PubMed ID: 15486392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients.
    Prielipp RC; Coursin DB; Scuderi PE; Bowton DL; Ford SR; Cardenas VJ; Vender J; Howard D; Casale EJ; Murray MJ
    Anesth Analg; 1995 Jul; 81(1):3-12. PubMed ID: 7598277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults.
    Warr J; Thiboutot Z; Rose L; Mehta S; Burry LD
    Ann Pharmacother; 2011 Sep; 45(9):1116-26. PubMed ID: 21828347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Observational Study of the Efficacy of Cisatracurium Compared with Vecuronium in Patients with or at Risk for Acute Respiratory Distress Syndrome.
    Sottile PD; Kiser TH; Burnham EL; Ho PM; Allen RR; Vandivier RW; Moss M;
    Am J Respir Crit Care Med; 2018 Apr; 197(7):897-904. PubMed ID: 29241014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Train-of-Four Values and Gas Exchange Indices in Moderate to Severe Acute Respiratory Distress Syndrome.
    Groetzinger LM; Rivosecchi RM; Kane-Gill SL; Donahoe MP
    Ann Pharmacother; 2016 Dec; 50(12):1009-1015. PubMed ID: 27511813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atracurium Versus Cisatracurium in the Treatment of Acute Respiratory Distress Syndrome.
    Carabetta SM; Allen B; Cannon C; Hailu K; Johnson T
    J Pharm Technol; 2023 Oct; 39(5):212-217. PubMed ID: 37745727
    [No Abstract]   [Full Text] [Related]  

  • 19. Perceived safety and efficacy of neuromuscular blockers for acute respiratory distress syndrome among medical intensive care unit practitioners: A multicenter survey.
    Torbic H; Bauer SR; Personett HA; Dzierba AL; Stollings JL; Ryder LP; Daniels CE; Caples SM; Frazee EN
    J Crit Care; 2017 Apr; 38():278-283. PubMed ID: 28012426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to rocuronium and cisatracurium in a patient with a spinal injury and acute respiratory distress syndrome.
    Riley K; Yampolsky N; Hakma Z; Moussouttas M
    Am J Health Syst Pharm; 2015 Apr; 72(8):632-5. PubMed ID: 25825186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.